---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-009989"
form_type: "8-K"
ticker: "PLX"
cik: "0001006281"
company_name: "Protalix BioTherapeutics, Inc."
filed_at: "2025-08-01T23:59:59+00:00"
generated_at: "2026-05-17T21:43:19.210287+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Protalix BioTherapeutics resolves stockholder class action; pays $160k fees

## Summary
- Plaintiff Kevin Mathew Thomas filed suit on March 10, 2025, challenging certain bylaws provisions under Delaware law.
- On May 8, 2025, the Board amended the challenged bylaws, rendering plaintiff's claims moot.
- Company agreed to pay $160,000 in fees and expenses to plaintiff's counsel; no admission of wrongdoing.
- Court entered dismissal with prejudice as to plaintiff on July 23, 2025.

## SEC filing metadata
- accession: 0001558370-25-009989
- form_type: 8-K
- ticker: PLX
- cik: 0001006281
- company_name: Protalix BioTherapeutics, Inc.
- filed_at: 2025-08-01T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006281/000155837025009989/0001558370-25-009989-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006281/000155837025009989/plx-20250801x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-009989
- JSON: https://secwatch.observer/filing/0001558370-25-009989.json
- Plain text: https://secwatch.observer/filing/0001558370-25-009989.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.